NousCom presents at 3rd Annual Immuno-Oncology BD&L and Investment Forum - Nouscom

NousCom presents at 3rd Annual Immuno-Oncology BD&L and Investment Forum

By fabiocrognale

Posted 06/02/2017

In External Presentations

EMBL Heidelberg, Germany

Full program: https://am.asco.org

Recent Posts

Nouscom Presents New Positive Translational Phase 1b Data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy, in a Late-Breaking Abstract at AACR 2023
Nouscom Announces AACR 2023 Late-Breaking Presentation of Translational Phase 1b Data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy
NOUSCOM ANNOUNCES THE PROMOTIONS OF LOREDANA SIANI TO VICE PRESIDENT OF TECHNICAL AND CMC DEVELOPMENT, TIFFANY BROOKE MULLER TO SENIOR VICE PRESIDENT OF FINANCE AND MORENA D’ALISE TO VICE PRESIDENT OF IMMUNOLOGY
Nouscom announces appointment of Sarah Runswick as Senior Director of Clinical Science

error: Content is protected !!!